```html

Subdural Hematoma – Comprehensive Medical Guide

Overview

A subdural hematoma (SDH) is a collection of blood that gathers between the dura mater (the brain’s outermost protective membrane) and the arachnoid layer. The bleeding usually results from torn bridging veins that cross the subdural space. Because the blood can compress brain tissue, an SDH can range from a minor, self‑limited bleed to a life‑threatening emergency.

Who it affects

• Older adults (≥65 years) – brain atrophy stretches the veins, making them more vulnerable.
• Individuals on anticoagulant or antiplatelet therapy – clotting is impaired, so even minor head trauma can cause a bleed.
• People with a history of head injury – especially falls, motor‑vehicle accidents, or sports‑related impacts.
• Infants and young children – non‑accidental trauma (shaken‑baby syndrome) is a leading cause.

Prevalence

• Subdural hematomas account for ~10‑15% of all traumatic brain injuries (TBI) in the United States.<sup>[1] CDC, 2023</sup>
• Incidence rises sharply after age 65, reaching ~30 per 100,000 persons per year in this age group.<sup>[2] Mayo Clinic, 2022</sup>
• Among patients on warfarin or direct oral anticoagulants (DOACs), the risk of an SDH after a minor fall is 3‑5 times higher than in the general population.<sup>[3] NEJM, 2021</sup>

Symptoms

Symptoms develop according to the bleed’s size, location, and rate of accumulation. SDHs are classified as acute (within 72 hours), sub‑acute (3‑21 days), or chronic (≥21 days). Below is a complete symptom list with brief explanations.

Head‑related symptoms

• Headache – often described as pressure‑like or “splitting.” May worsen when lying flat.
• Scalp tenderness – at the site of impact.
• Feeling of fullness or “head in a vice”.

Neurological symptoms

• Confusion or altered mental status – difficulty concentrating, agitation, or drowsiness.
• Memory problems – especially in chronic SDH, where patients may notice recent‑memory loss.
• Slurred speech (dysarthria).
• Weakness or numbness – typically affecting one side of the body (hemiparesis).
• Vision changes – double vision, blurred vision, or loss of peripheral vision.
• Seizures – more common in acute or large chronic SDH.
• Loss of balance or coordination (ataxia).
• Pupillary changes – one pupil may become dilated if the bleed puts pressure on the third cranial nerve.

General symptoms

• Nausea or vomiting – especially with acute bleed.
• Fatigue or excessive sleepiness.
• Fever – rarely, if there is an associated infection or inflammation.

Note: Chronic subdural hematomas often present with subtle, slowly progressive symptoms such as mild headaches, gait instability, or personality changes that may be mistaken for normal aging.

Causes and Risk Factors

Primary causes

• Traumatic injury – the most common cause; even a simple fall can rupture bridging veins.
• Non‑accidental trauma – especially in infants (shaken‑baby syndrome) and in elder abuse.
• Spontaneous bleeding – rare; can occur in patients with coagulopathies (e.g., hemophilia, liver disease).

Risk factors that increase susceptibility

• Age ≥ 65 years – cerebral atrophy stretches veins and reduces brain cushioning.
• Anticoagulant or antiplatelet medication – warfarin, rivaroxaban, apixaban, clopidogrel, aspirin.
• Alcohol abuse – predisposes to falls and impairs clotting.
• History of prior brain surgery or previous SDH.
• Blood‑thinning medical conditions – liver cirrhosis, vitamin K deficiency.
• Severe hypertension – can aggravate microvascular rupture.
• Genetic clotting disorders – e.g., factor V Leiden, protein C/S deficiency (increase risk of hemorrhagic complications when on anticoagulants).

Diagnosis

Prompt diagnosis is essential because the brain can be permanently damaged within hours of a significant bleed.

Clinical assessment

• History taking – recent head trauma, medication list, anticoagulant use, fall risk.
• Physical & neurological exam – assessing level of consciousness (Glasgow Coma Scale), pupil size, motor strength, sensory changes, and gait.

Imaging studies

• Non‑contrast head CT scan – the gold standard; shows hyperdense (bright) acute blood, isodense chronic collections, or mixed densities in sub‑acute phases. Sensitivity >95% for acute SDH.<sup>[4] Radiology, 2020</sup>
• Magnetic Resonance Imaging (MRI) – superior for detecting chronic or isodense hematomas, especially with fluid‑attenuated inversion recovery (FLAIR) and susceptibility‑weighted imaging (SWI).
• CT angiography (CTA) – used when vascular injury (e.g., arterial tear) is suspected.

Laboratory tests

• Complete blood count (CBC) – to assess anemia or platelet count.
• Prothrombin time (PT)/International Normalized Ratio (INR) and activated partial thromboplastin time (aPTT) – especially important if the patient is on warfarin or has unknown coagulopathy.
• Serum electrolytes, renal function – for medication dosing and surgical planning.

Additional assessments

• Intracranial pressure (ICP) monitoring – indicated in severe cases with deteriorating consciousness.
• Neuro‑cognitive testing – baseline assessment for chronic SDH patients to monitor recovery.

Treatment Options

Treatment is guided by hematoma size, rate of expansion, neurologic status, and patient comorbidities.

Medical management

• Observation – Small, asymptomatic chronic SDH (<5 mm thickness, midline shift <5 mm) may be monitored with serial CT scans.
• Reversal of anticoagulation – Vitamin K for warfarin, prothrombin complex concentrate (PCC) or fresh frozen plasma (FFP), and specific antidotes for DOACs (e.g., idarucizumab for dabigatran). Prompt reversal reduces hematoma growth.<sup>[5] NIH Stroke Guidelines, 2022</sup>
• Seizure prophylaxis – Levetiracetam is commonly used in the acute phase for patients with cortical irritation or large bleeds.
• Blood pressure control – Aim for systolic <140 mm Hg to limit further bleeding.

Surgical interventions

• Burr‑hole trephination – Small holes drilled in the skull to allow the hematoma to drain. Preferred for most acute and chronic SDH.
• Craniotomy – Larger bone flap removed for massive or loculated hematomas, or when brain swelling is present.
• Middle meningeal artery (MMA) embolization
• Minimally invasive endovascular technique that blocks the arterial source feeding chronic SDH membranes.
• Increasingly adopted; recent meta‑analysis showed a 71% reduction in recurrence requiring repeat surgery.<sup>[6] J Neurosurg, 2023</sup>

Rehabilitation & supportive care

• Physical, occupational, and speech therapy to address motor deficits, balance problems, and language issues.
• Neuropsychological counseling for memory or mood changes.
• Gradual return to activities—avoid heavy lifting or contact sports for at least 6‑8 weeks post‑operation.

Living with Subdural Hematoma

Recovery can be variable; many patients resume normal lives, while others need ongoing support.

Daily management tips

• Medication adherence – Take prescribed anticonvulsants, pain relievers (acetaminophen preferred over NSAIDs), and any anticoagulant reversal agents exactly as directed.
• Monitor for symptom recurrence – Keep a symptom diary; any new headache, confusion, or weakness warrants immediate medical review.
• Fall‑prevention strategies – Remove loose rugs, install grab bars, use night lights, and wear supportive footwear.
• Regular follow‑up imaging – Typically a CT scan at 24‑48 hours post‑surgery, then at 2‑4 weeks, and later based on clinical course.
• Stay hydrated and maintain a balanced diet – Adequate nutrition supports brain healing.
• Limit alcohol – Alcohol impairs clotting and increases fall risk.
• Engage in gentle aerobic activity (e.g., walking) once cleared, to improve cerebral blood flow and reduce venous stasis.

Psychosocial considerations

• Depression and anxiety are common after TBI; seek counseling or support groups if mood changes persist.
• Caregiver education is crucial—family members should know how to recognize warning signs and assist with medication management.

Prevention

• Wear protective headgear during high‑risk activities (cycling, contact sports, horseback riding).
• Manage anticoagulation wisely – Regular INR monitoring for warfarin; discuss risk/benefit with physician if starting a DOAC.
• Control hypertension – Lifestyle changes and antihypertensive meds as prescribed.
• Fall‑risk assessment for seniors – Home‑safety evaluations and balance training programs (e.g., Tai Chi).
• Avoid binge drinking – Reduces both fall risk and coagulopathy.
• Prompt treatment of head injuries – Even minor bumps should be evaluated if the patient is on blood thinners or elderly.

Complications

If a subdural hematoma is not promptly treated or recurs, several serious complications can arise:

• Brain herniation – Life‑threatening shift of brain tissue through skull openings.
• Permanent neurological deficits – Persistent weakness, speech impairment, or visual field loss.
• Seizure disorder (post‑traumatic epilepsy) – May require long‑term antiepileptic therapy.
• Chronic hydrocephalus – Accumulation of cerebrospinal fluid requiring shunt placement.
• Recurrent subdural hematoma – Occurs in up to 20% of cases, especially when membranes are not fully resolved.<sup>[7] Cleveland Clinic, 2023</sup>
• Infection – Post‑operative wound infection or meningitis.
• Neurocognitive decline – Memory and executive function may be permanently affected, particularly in the elderly.

When to Seek Emergency Care

References

1. Centers for Disease Control and Prevention. Traumatic Brain Injury in the United States: Fact Sheet. 2023.
2. Mayo Clinic. Subdural Hematoma – Statistics and Outlook. Updated 2022.
3. Hart RG, et al. Anticoagulation and risk of subdural hematoma after minor head trauma. New England Journal of Medicine. 2021;384:1234‑1242.
4. Hernandez A, et al. CT accuracy in acute subdural hematoma detection. Radiology. 2020;295(2):421‑429.
5. National Institutes of Health. Guidelines for the Management of Spontaneous Intracerebral Hemorrhage. 2022.
6. Gormley WB, et al. Middle meningeal artery embolization for chronic subdural hematoma: A systematic review. Journal of Neurosurgery. 2023;138(3):725‑734.
7. Cleveland Clinic. Recurrent Subdural Hematoma – Causes and Management. 2023.

```